Hulie Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hulie Zeng has a total of 111 co-authors. Here are the top co-authors by number of shared publications:
- Katsumi Uchiyama
Department of Applied Chemistry, Graduate School of Urban Environmental Sciences, Tokyo Metropolitan University, Minamiohsawa, Hachioji, Tokyo, 192-0397, Japan
18 shared publications Hizuru Nakajima
Department of Environmental Applied Chemistry, Tokyo Metropolitan University, Minamiohsawa, Hachioji, Tokyo, 192-0397, Japan
12 shared publications- Danhong Wu
Department of Neurology, Shanghai Fifth People’s Hospital, Fudan University, Shanghai, China
6 shared publications - Jin-Ming Lin
Department of Chemistry, Beijing Key Laboratory of Microanalytical Methods and Instrumentation, Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology (Ministry of Education), Tsinghua University, Beijing 100084, P. R. China
6 shared publications - Hizuru Nakajima
Department of Applied Chemistry for Environment, Graduate School of Urban Environmental Sciences, Tokyo Metropolitan University
5 shared publications Yong Zhang
Department of Applied Chemistry, Graduate School of Urban Environmental Sciences , Tokyo Metropolitan University , Minamiohsawa , Hachioji, Tokyo 192-0397 , Japan
5 shared publications
Latest Publications
- 4 July 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 312, 118991
Antiviral Drug Discovery Strategy Based on Raman Imaging Technology
- 4 July 2026
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 312, 118991
Antiviral Drug Discovery Strategy Based on Raman Imaging Technology
- 7 June 2026
- Published by Elsevier in Phytomedicine
- Vol. 158, 158393
Lipid-mediated broad-spectrum antiviral mechanism of alpha-linolenic acid against respiratory enveloped viruses
- 7 June 2026
- Published by Elsevier in Phytomedicine
- Vol. 158, 158393
Lipid-mediated broad-spectrum antiviral mechanism of alpha-linolenic acid against respiratory enveloped viruses
- 25 March 2026
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 200
Insights into the efficacy and safety of CAR-T therapies using organoids and organs-on-chips
- 25 March 2026
- Published by Elsevier in TrAC Trends in Analytical Chemistry
- Vol. 200
Insights into the efficacy and safety of CAR-T therapies using organoids and organs-on-chips
- Open Access
- 22 December 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (12) , e71143
Insulin Resistance and Cognitive Function in Nondiabetic Patients With Cerebral Small Vessel Disease: Role of Brain Glymphatic Function
Objective: Both insulin sensitivity and brain glymphatic function were linked to cognitive function in nondiabetic patients with cerebral small vessel disease (CSVD). This study aims to elucidate these complex associations through mediation analysis. Methods: Patients who underwent multimodal magnetic resonance imaging (MRI) scans were recruited. Global cognitive assessment was performed by Mini‐Mental State Examination (MMSE), four isolated cognitive domains were assessed simultaneously. Glymphatic function was assessed using the diffusion tensor imaging along the perivascular space (DTI‐ALPS) index, insulin sensitivity was assessed by the homeostasis model assessment–estimated insulin resistance index (HOMA‐IR), and HOMA‐IR≥2.80 was defined as insulin resistance (IR). Mediation analysis was conducted to examine the effect of the DTI‐ALPS on insulin sensitivity and cognitive function. Results: 110 CSVD patients were recruited, 40 patients were IR and 70 patients were non‐IR. Both the HOMA‐IR and DTI‐ALPS index were significant predictors of cognitive function, with B = −0.592, 95%CI, −0.939 to −0.244, p = 0.001 and B = 9.378, 95% CI, 3.376 to 15.381, p = 0.003, respectively, after adjusting for age, sex, and other confounding factors. Mediation analysis revealed that the DTI‐ALPS index served as a significant partial mediator in the relationship between HOMA‐IR and cognitive function, with direct effect = −0.649 (95% CI, −1.015 to −0.282, p < 0.001), total effect = −0.743 (95% CI, −1.106 to −0.380, p < 0.001), and the indirect effect = −0.094 (95% CI, −0.236 to −0.006, p = 0.029), accounting for 12.66% of the total effect. Conclusion: Both the HOMA‐IR and the DTI‐ALPS index are independent risk factors for cognitive function. Furthermore, the DTI‐ALPS index significantly and partially mediates the relationship between the HOMA‐IR and cognitive function.
- 22 December 2025
- Published by Wiley in Brain and Behavior
- Vol. 15 (12) , e71143
Open AccessInsulin Resistance and Cognitive Function in Nondiabetic Patients With Cerebral Small Vessel Disease: Role of Brain Glymphatic Function
Objective: Both insulin sensitivity and brain glymphatic function were linked to cognitive function in nondiabetic patients with cerebral small vessel disease (CSVD). This study aims to elucidate these complex associations through mediation analysis. Methods: Patients who underwent multimodal magnetic resonance imaging (MRI) scans were recruited. Global cognitive assessment was performed by Mini‐Mental State Examination (MMSE), four isolated cognitive domains were assessed simultaneously. Glymphatic function was assessed using the diffusion tensor imaging along the perivascular space (DTI‐ALPS) index, insulin sensitivity was assessed by the homeostasis model assessment–estimated insulin resistance index (HOMA‐IR), and HOMA‐IR≥2.80 was defined as insulin resistance (IR). Mediation analysis was conducted to examine the effect of the DTI‐ALPS on insulin sensitivity and cognitive function. Results: 110 CSVD patients were recruited, 40 patients were IR and 70 patients were non‐IR. Both the HOMA‐IR and DTI‐ALPS index were significant predictors of cognitive function, with B = −0.592, 95%CI, −0.939 to −0.244, p = 0.001 and B = 9.378, 95% CI, 3.376 to 15.381, p = 0.003, respectively, after adjusting for age, sex, and other confounding factors. Mediation analysis revealed that the DTI‐ALPS index served as a significant partial mediator in the relationship between HOMA‐IR and cognitive function, with direct effect = −0.649 (95% CI, −1.015 to −0.282, p < 0.001), total effect = −0.743 (95% CI, −1.106 to −0.380, p < 0.001), and the indirect effect = −0.094 (95% CI, −0.236 to −0.006, p = 0.029), accounting for 12.66% of the total effect. Conclusion: Both the HOMA‐IR and the DTI‐ALPS index are independent risk factors for cognitive function. Furthermore, the DTI‐ALPS index significantly and partially mediates the relationship between the HOMA‐IR and cognitive function.
- Open Access
- 28 November 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 978
Radiomics models identifying dementia in patients with normal age-related hippocampal atrophy: a study based on machine learning
Our study aimed to employ a machine learning models based on radiomics for automated dementia identification in cerebral small vessel disease (CSVD) patien
- 28 November 2025
- Published by Springer Nature in BMC Geriatrics
- Vol. 25 (1) , 978
Open AccessRadiomics models identifying dementia in patients with normal age-related hippocampal atrophy: a study based on machine learning
Our study aimed to employ a machine learning models based on radiomics for automated dementia identification in cerebral small vessel disease (CSVD) patien
- Open Access
- 1 September 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 258, 109143
Glymphatic function, deep medullary veins, and cognitive impairment in cerebral small vessel disease: A mediation analysis
- 1 September 2025
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 258, 109143
Open AccessGlymphatic function, deep medullary veins, and cognitive impairment in cerebral small vessel disease: A mediation analysis
- 2 October 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (41) , 16280-16288
Dynamic Liver Chip Based on Well-Coupled Microfluidics: An Accurate NASH Model for Drug Evaluation
The convenient liver model in vitro recapitulating the hepatic functions, metabolism, and even steatohepatitis to perform the accurate drug evaluation is still challenging because of the unattainable hominine physiological microenvironment in vitro. Here, the progressed stages of nonalcoholic steatohepatitis (NASH) disease were precisely modeled to accurately evaluate the performance of antilipemic based on the dynamic liver chip adopting the well-coupled microfluidics, which well recapitulated the normal and steatohepatitis of liver in vitro. In brief, the mild nutrient flow and sufficient oxygen supply for parenchymal liver cells could be well supplied through the endothelial cells layer that mimicked the real physiological barrier of endothelium, while the loading of drugs might be obtained by directly adding drug into the running nutrient flow to mimic the intravenously administrable. The progressed degree of steatohepatitis could be directly reflected by the amount of intramyocellular lipid content (IMLC) of the HepG2 cell hepatocyte layer in wells that were induced by different concentrations of free fatty acids (FFA). To prove the concept of the liver chip in drug evaluation, an accurate assessment of the performance of firsocostat, the acetyl-CoA carboxylase (ACC) inhibitor of hepatic mitochondria of hepatocytes, was carried out. The subtle time dependence of firsocostat treatment to different progressed stages of NASH was clearly figured out. Therefore, we prospect the liver chip that adopted well-coupled microfluidics could be an accurate and standard liver model in vitro to carry out the antilipemic evaluation and screening, which significantly enlightens the drug evaluation by liver on chip in vitro.
- 2 October 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (41) , 16280-16288
Dynamic Liver Chip Based on Well-Coupled Microfluidics: An Accurate NASH Model for Drug Evaluation
The convenient liver model in vitro recapitulating the hepatic functions, metabolism, and even steatohepatitis to perform the accurate drug evaluation is still challenging because of the unattainable hominine physiological microenvironment in vitro. Here, the progressed stages of nonalcoholic steatohepatitis (NASH) disease were precisely modeled to accurately evaluate the performance of antilipemic based on the dynamic liver chip adopting the well-coupled microfluidics, which well recapitulated the normal and steatohepatitis of liver in vitro. In brief, the mild nutrient flow and sufficient oxygen supply for parenchymal liver cells could be well supplied through the endothelial cells layer that mimicked the real physiological barrier of endothelium, while the loading of drugs might be obtained by directly adding drug into the running nutrient flow to mimic the intravenously administrable. The progressed degree of steatohepatitis could be directly reflected by the amount of intramyocellular lipid content (IMLC) of the HepG2 cell hepatocyte layer in wells that were induced by different concentrations of free fatty acids (FFA). To prove the concept of the liver chip in drug evaluation, an accurate assessment of the performance of firsocostat, the acetyl-CoA carboxylase (ACC) inhibitor of hepatic mitochondria of hepatocytes, was carried out. The subtle time dependence of firsocostat treatment to different progressed stages of NASH was clearly figured out. Therefore, we prospect the liver chip that adopted well-coupled microfluidics could be an accurate and standard liver model in vitro to carry out the antilipemic evaluation and screening, which significantly enlightens the drug evaluation by liver on chip in vitro.
- 22 May 2024
- Published by Elsevier in Microchemical Journal
- Vol. 204
Highly precisive digital polymerase chain reaction based on inkjet printer
- 22 May 2024
- Published by Elsevier in Microchemical Journal
- Vol. 204
Highly precisive digital polymerase chain reaction based on inkjet printer
- 20 April 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (17) , 6738-6745
Microsphere-Enhanced Fluorescence-Lightened Solid-Phase Hybridization Assay: The Strategy to Highly Selective Detection of Micro Ribonucleic Acids
The detection of low-abundance microribonucleic acid (miRNA) frequently adopted nucleic acid sequence-based amplification detection, which was found to have poor selectivity for the nonspecific amplification of template-dependent ligation in enzyme-mediated cascade reactions. Here, a highly selective detection of miRNAs was developed that combined microsphere-enhanced fluorescence (MSEF) and solid-phase base-paired hybridization. The target miRNA could be accurately and quantitatively identified through the solid-phase hybridization assay on the surface of an optical microsphere, while the detected fluorescence signal could be physically amplified by MSEF. Hereinto, the optical microsphere acted as the fluorescence amplifier and whose surface supplied the space to carry out base-paired hybridization to recognize the target miRNA via the immobilized capture DNA sequence. The detected fluorescence signal of the single-base mismatched miRNA-21 sequence was just around 12% of that of the target miRNA-21 sequence in the measurement of model miRNA-21, while the limit of detection of miRNA-21 could be 1.0 fM. The developed detection of miRNA on an optical microsphere was demonstrated to be an excellent physically amplified method to selectively and sensitively detect the target miRNA and magnificently avoid the nonspecific amplification and false-positive results, which is expected to have wide applications in pathematology, pharmacology, clinic diagnosis, and on-site screening fields as well.
- 20 April 2024
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 96 (17) , 6738-6745
Microsphere-Enhanced Fluorescence-Lightened Solid-Phase Hybridization Assay: The Strategy to Highly Selective Detection of Micro Ribonucleic Acids
The detection of low-abundance microribonucleic acid (miRNA) frequently adopted nucleic acid sequence-based amplification detection, which was found to have poor selectivity for the nonspecific amplification of template-dependent ligation in enzyme-mediated cascade reactions. Here, a highly selective detection of miRNAs was developed that combined microsphere-enhanced fluorescence (MSEF) and solid-phase base-paired hybridization. The target miRNA could be accurately and quantitatively identified through the solid-phase hybridization assay on the surface of an optical microsphere, while the detected fluorescence signal could be physically amplified by MSEF. Hereinto, the optical microsphere acted as the fluorescence amplifier and whose surface supplied the space to carry out base-paired hybridization to recognize the target miRNA via the immobilized capture DNA sequence. The detected fluorescence signal of the single-base mismatched miRNA-21 sequence was just around 12% of that of the target miRNA-21 sequence in the measurement of model miRNA-21, while the limit of detection of miRNA-21 could be 1.0 fM. The developed detection of miRNA on an optical microsphere was demonstrated to be an excellent physically amplified method to selectively and sensitively detect the target miRNA and magnificently avoid the nonspecific amplification and false-positive results, which is expected to have wide applications in pathematology, pharmacology, clinic diagnosis, and on-site screening fields as well.